Minerva Neurosciences | NERV - Market Capitalization

Stock Price
6.27
Daily Change
-0.04 -0.63%
Monthly
45.14%
Yearly
219.90%
Q1 Forecast
2.46

Minerva Neurosciences reported $44.1M in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.6B 10M Sep/2025
Adma Biologics USD 3.49B 853M Sep/2025
ALKERMES USD 4.95B 235M Sep/2025
Alterity Therapeutics Limited AUD 11M 5M Jun/2023
AstraZeneca USD 222.33B 65.82B Feb/2026
BioCryst Pharmaceuticals USD 1.23B 115M Dec/2023
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Cipla INR 1.22T 6.47B Dec/2025
Clal Biotechnology ILS 47.99M 4.37M Jan/2026
Compugen USD 137.5M 21.89M Sep/2025
CSL USD 76.3B 60.04B Jun/2025
Dynavax Technologies USD 1.16B 26M Sep/2025
Eli Lilly USD 1.01T 3.37B Feb/2026
Esperion Therapeutics USD 340M 235M Dec/2023
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
Grifols EUR 6.77B 773M Sep/2025
Halozyme Therapeutics USD 8.58B 2.17B Sep/2025
Ionis Pharmaceuticals USD 10.43B 4.14B Sep/2025
J&J USD 500.24B 67.44B Dec/2025
Merck USD 300.37B 39.11B Feb/2026
Minerva Neurosciences USD 43M 5M Dec/2023
Neurocrine Biosciences USD 13.7B 221M Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Novavax USD 684M 43M Sep/2023
Pfizer USD 152.89B 11.32B Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Takeda JPY 7.64T 774.9B Dec/2025
Vanda Pharmaceuticals USD 243M 136M Dec/2023